MarketInOut Stock Screener Log In | Sign Up
 

MindMaze Therapeutics Holding S.A.

SIX • Healthcare • Biotechnology • Quote as of 05/13/2026
MindMaze Therapeutics Holding S.A. stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeSIX
Market Capitalization48.99 mln

1-Year Forecast

3.41
Transformational upside

Relative Strength

100 / 100
Top performer

Debt / Equity

0.05
Debt-free

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Payout Ratio

0%
No payout

Business Description

Founded in 2025 and headquartered in Lausanne, Switzerland, MindMaze Therapeutics builds technology designed to help patients with neurological conditions. The company combines brain science with digital treatment tools to tackle serious and widespread health problems in the field of neurology.

Key Fundamentals

EPS-0.48
EV / EBITDA-4.29
EV / EBIT-3.56
EV / Revenue53.42

Financial Strength

1-Year Target Price3.41

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.28% 26 / 100   
1 Month 43.12% 99 / 100   
2 Months -65.93% 0 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us